BioSpace News Archive

Fact.MR – A Market Research and Competitive Intelligence Provider: Sales in the breast cancer diagnostics market surpassed US$ 4 Bn through 2020, estimates Fact.MR.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per a comprehensive survey by Fact.MR, the global rapid medical diagnostic kits market is projected to top US$ 23.1 Bn in 2031.

The research analysts at Transparency Market Research project that the global atrial fibrillation market will witness a significant CAGR of 11 % over the forecast period of 2017 to 2026.

Takeda Pharmaceutical Company Limited announced financial results for the first half of fiscal year 2021.

BioInvent International AB invites to a presentation of the third quarter report 2021 and a telephone conference with CEO Martin Welschof.

Edgewise Therapeutics, Inc. announced positive topline results from the MAD portion of a first-in-human Phase 1 clinical trial assessing the safety, tolerability, PK and PD of escalating doses of EDG-5506, an orally administered small molecule myosin inhibitor designed to protect injury-susceptible fast skeletal muscle fibers in dystrophinopathies such as DMD and BMD.

Leading NMR diagnostics company numares AG announced that the company signed an exclusive licence agreement with Oxford University Innovation.

Genocea Biosciences, Inc. today provided a business update for the third quarter ended September 30, 2021.

Clearside Biomedical, Inc. announced today that its third quarter 2021 financial results will be reported on Wednesday, November 10, 2021 after the close of the financial markets.

Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the third quarter ended September 30, 2021 on Monday, November 15, 2021 at 4:30 p.m. ET ( 1:30 p.m. PT ).